CN1149475A - 一种治疗抑郁型精神病的宁神药物组合物 - Google Patents
一种治疗抑郁型精神病的宁神药物组合物 Download PDFInfo
- Publication number
- CN1149475A CN1149475A CN 95117411 CN95117411A CN1149475A CN 1149475 A CN1149475 A CN 1149475A CN 95117411 CN95117411 CN 95117411 CN 95117411 A CN95117411 A CN 95117411A CN 1149475 A CN1149475 A CN 1149475A
- Authority
- CN
- China
- Prior art keywords
- depressive psychosis
- medicine
- radix
- ningshen
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000028017 Psychotic disease Diseases 0.000 title claims abstract description 20
- 230000003001 depressive effect Effects 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 7
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229960000836 amitriptyline Drugs 0.000 claims abstract description 11
- BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 claims abstract description 9
- 229960004940 sulpiride Drugs 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241000489492 Arisaema Species 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 210000000941 bile Anatomy 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 abstract description 54
- 230000000694 effects Effects 0.000 abstract description 33
- 239000000126 substance Substances 0.000 abstract description 15
- 231100000331 toxic Toxicity 0.000 abstract description 12
- 230000002588 toxic effect Effects 0.000 abstract description 12
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 7
- 239000002775 capsule Substances 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 4
- 229960001076 chlorpromazine Drugs 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000007086 side reaction Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 231100001274 therapeutic index Toxicity 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 206010048610 Cardiotoxicity Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000164439 Curcuma angustifolia Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 231100000259 cardiotoxicity Toxicity 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960004801 imipramine Drugs 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95117411A CN1054523C (zh) | 1995-11-06 | 1995-11-06 | 一种治疗抑郁型精神病的宁神药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95117411A CN1054523C (zh) | 1995-11-06 | 1995-11-06 | 一种治疗抑郁型精神病的宁神药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1149475A true CN1149475A (zh) | 1997-05-14 |
CN1054523C CN1054523C (zh) | 2000-07-19 |
Family
ID=5081208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95117411A Expired - Fee Related CN1054523C (zh) | 1995-11-06 | 1995-11-06 | 一种治疗抑郁型精神病的宁神药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1054523C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547861A (zh) * | 2014-12-29 | 2015-04-29 | 永春县达埔联发香业有限公司 | 一种养心安神,解郁助眠的药物或保健品组合物及其制备方法和用途 |
-
1995
- 1995-11-06 CN CN95117411A patent/CN1054523C/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547861A (zh) * | 2014-12-29 | 2015-04-29 | 永春县达埔联发香业有限公司 | 一种养心安神,解郁助眠的药物或保健品组合物及其制备方法和用途 |
CN104547861B (zh) * | 2014-12-29 | 2017-12-15 | 永春县达埔联发香业有限公司 | 一种养心安神,解郁助眠的药物或保健品组合物及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN1054523C (zh) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR19980033798A (ko) | 당뇨병 치료용 의약조성물 | |
CN1224614A (zh) | 防治心脑血管系统疾病药物及其制备方法 | |
CN1122522C (zh) | 一种治疗抑郁型精神病的药物 | |
CN101954031B (zh) | 一种治疗血管性痴呆的药物及制备方法 | |
CN1054523C (zh) | 一种治疗抑郁型精神病的宁神药物组合物 | |
CN100493556C (zh) | 一种治疗抑郁情绪障碍性疾病的药物 | |
CN101249207A (zh) | 一种治疗冠心病的药物配方 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN1219416A (zh) | 一种治疗“消极抑郁型”精神病的药物组合物 | |
CN107648397B (zh) | 一种用于治疗肝肾阴虚型的中药组合物及其制备方法和应用 | |
CN1212149C (zh) | 治疗儿童多动症的中药制剂及其制备方法 | |
CN1895504A (zh) | 一种治疗骨质疏松症的中药及制备方法 | |
CN1056765C (zh) | 治疗慢性退缩型精神病的宁神药物组合物 | |
CN104436049A (zh) | 一种治疗心脏病的中药组合物 | |
CN100464767C (zh) | 用于治疗高尿酸血症的药物组合物 | |
CN1052896C (zh) | 一种抗精神病的宁神药物组合物 | |
CN1054525C (zh) | 一种治疗“下消”型糖尿病的药物组合物 | |
CN101322762B (zh) | 一种治疗糖尿病的药物组合物 | |
CN1463734A (zh) | 一种治疗糖尿病的中成药及其制备方法 | |
CN102727730B (zh) | 治疗男性不育的复方中药制剂及其制备方法 | |
CN1097333A (zh) | 一种纯植物保健制剂糖脂消及其制法 | |
CN1219415A (zh) | 一种治疗"慢性退缩型"精神病的药物组合物 | |
CN1048639C (zh) | 一种具有消除毒瘾扶正作用的胶囊 | |
CN1306830A (zh) | 一种治疗ⅱ型糖尿病的药物 | |
CN105998752A (zh) | 一种防治血管性痴呆的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Co-applicant after: Lin Yulin Co-applicant before: Zong Yuhua |
|
CB03 | Change of inventor or designer information |
Inventor after: Lin Yulin Inventor after: Chen Jinhua Inventor after: Lin Zuxian Inventor after: Fu Chunfu Inventor before: Chen Jinhua Inventor before: Lin Zuxian Inventor before: Fu Chunfu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN JINHUA; LIN ZUXIAN; FU CHUNFU TO: LIN YULIN; CHEN JINHUA; LIN ZUXIAN;FU CHUNFU |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |